Hill September 15, 2023
Joseph Choi

The Southern District Court of Ohio on Friday heard oral arguments from the federal government and the Chamber of Commerce in the latter’s lawsuit challenging the Medicare Drug Price Negotiation Program, with both sides rehashing long-held assertions.

The Chamber has requested that the Medicare negotiation program be blocked from operating, with the organization asking for a decision by Oct. 1, by which companies whose products have been named must sign an agreement if they choose to engage in the process.

Here are some of the key points that were argued on Friday:

Lack of standing

In a prior motion to dismiss, the federal government argued the Chamber of Commerce has no standing to file a lawsuit as it is not...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article